Agaricus blazei Murill: The Brazilian Sun Mushroom Your Immune System Might Thank You For

If you've spent any time researching functional mushrooms, you've probably heard the same five names repeated like a mantra: lion's mane, reishi, chaga, turkey tail, cordyceps. They are the Beatles of the mushroom supplement world — famous, well-studied, and very hard to avoid at any health food store.

But medicine has a long history of overlooking things that don't fit the popular narrative. Agaricus blazei Murill — known variously as the "sun mushroom," "royal sun agaricus," or cogumelo do sol in its native Brazil — is one of those overlooked contenders. It sits outside the usual conversation, gets less shelf space, and rarely makes it into listicles about "the best mushrooms for immunity." That's a shame, because the clinical evidence behind it is, in some respects, more direct than what we have for several of its more famous cousins.

Let me tell you what I found when I dug into the research — and why I think it deserves a spot in that conversation.

01What Is Agaricus blazei Murill?

Agaricus blazei Murill (AbM) is an edible mushroom native to the Atlantic rainforest region of Brazil, discovered in the 1960s near a small village called Piedade, where locals had notably low rates of certain chronic diseases. (Whether that was actually due to the mushroom or just general lifestyle is, admittedly, correlation rather than causation — but it sparked several decades of research.) The fungus was subsequently introduced to Japan, where it became a focus of intense scientific interest and commercial cultivation.

Taxonomically, it belongs to the same genus as the common button mushroom you'd toss into a salad (Agaricus bisporus), though its bioactive profile is considerably more interesting. AbM is characterized by unusually high concentrations of beta-(1→6)-glucan polysaccharides — a structural distinction from the beta-(1→3)/(1→4)-glucans more common in other medicinal mushrooms. This subtle difference in molecular architecture appears to translate into meaningfully different biological activity, particularly regarding immune stimulation.

It also contains ergosterol (a precursor to vitamin D2), various triterpenoids, lectins, and ribonucleic acid fractions that have attracted their own research attention. But the beta-glucan profile is where most of the action seems to be.

02The Immune Case: What the Human Data Actually Shows

Here's where AbM earns its keep scientifically. A controlled clinical trial published in the International Journal of Gynecological Cancer looked at 100 patients with cervical, ovarian, and endometrial cancer who were undergoing platinum-based chemotherapy. Approximately half received standard chemotherapy plus an oral AbM extract (Agaricus blazei Murill Kyowa, or ABMK); the other half received chemotherapy with a placebo.

The results were notable: natural killer (NK) cell activity was significantly higher in the ABMK-treated group compared to the placebo group (p<0.002). NK cells are a critical front-line component of immune surveillance — they're the cells that identify and destroy virus-infected cells and early cancer cells before the adaptive immune system has time to mount a targeted response. In the context of chemotherapy, which typically hammers immune function alongside tumor cells, an intervention that preserves or enhances NK activity has real clinical relevance.

Beyond the immune numbers, ABMK treatment was associated with improved quality of life outcomes: better appetite, reduced hair loss severity, improved emotional stability, and decreased general weakness during the chemotherapy cycles. These aren't trivial endpoints — anyone who has watched a family member go through chemotherapy knows that quality of life is not a soft outcome.

Source: Ahn WS, et al. Int J Gynecol Cancer 2004. doi:10.1111/j.1048-891X.2004.14403.x — via PubMed.

I want to be clear about what this study does and doesn't tell us. It's a controlled trial, not a randomized double-blind placebo-controlled trial (the gold standard). The groups differed in size (39 ABMK, 61 placebo), and the chemotherapy regimens varied between patients. So I'm not presenting this as definitive proof that AbM extends survival or cures cancer. But it is real human data showing measurable immune-functional improvement in a clinical population — a bar that many popular supplements haven't cleared at all.

03The Broader Immunological Picture

A comprehensive 2008 review by Hetland and colleagues from the University of Oslo, published in the Scandinavian Journal of Immunology, examined the immunological properties of AbM across multiple studies and reached some useful conclusions. AbM extracts consistently showed immunomodulating properties, with effects on macrophage activation, T-helper cell balance (particularly shifting toward Th1 responses), and NK cell function.

One finding the authors highlighted — and which I think deserves emphasis for anyone shopping for supplements — is that they observed "highly different biological potency between AbM extracts of different source and manufacturing." This is not a small caveat. The authors found meaningful variation in immune activity depending on how the mushroom was grown, extracted, and processed. Two products calling themselves "Agaricus blazei" could have dramatically different biological effects depending on cultivation conditions and extraction methods.

Source: Hetland G, et al. Scand J Immunol 2008. doi:10.1111/j.1365-3083.2008.02156.x — via PubMed.

04Anti-Inflammatory and Antiallergic Effects

A more recent 2020 review in Nutrients by Hetland's group (they've clearly made AbM something of a specialty) expanded the picture considerably. Beyond immune stimulation, AbM showed evidence of anti-inflammatory and antiallergic activity in both preclinical and some clinical contexts.

The anti-inflammatory mechanisms appear to work through reduction of proinflammatory cytokines (TNF-α, IL-6, and related mediators), modulation of oxidative stress, and — interestingly — effects on gut microbiota composition. The gut microbiome angle is one I find particularly compelling, because it connects AbM's mechanism to the broader gut-immune axis that's become a major focus of modern immunology. Changing the microbial ecosystem can have cascading effects on systemic inflammation and immune tone that we're only beginning to fully map.

The antiallergic effects, the review notes, appear related to AbM's ability to correct a skewed Th1/Th2 balance. Allergic conditions — asthma, eczema, seasonal allergies — typically involve an overactive Th2 response relative to Th1. AbM's Th1-promoting activity could, theoretically, help restore that balance. There's preclinical data supporting this in animal models, though the human evidence remains limited.

The review also noted that AbM appears safe and may support longevity in animal models, possibly due to reduced tumorigenesis and oxidative damage. These longevity findings are still preliminary, but they fit neatly into the broader picture of an immunomodulatory, anti-inflammatory agent.

Source: Hetland G, et al. Nutrients 2020. doi:10.3390/nu12051339 — via PubMed.

05How AbM Compares to Other Medicinal Mushrooms for Immunity

AbM sits in an interesting position here: it has more direct human immune data than chaga or reishi, less than turkey tail, and a distinctly different mechanism from lion's mane. For someone specifically focused on immune support, it belongs in the conversation alongside turkey tail — not instead of it, but alongside it.

06Safety Profile: What We Know

AbM has been consumed as a food in Brazil and as a supplement in Japan for decades without significant safety signals emerging. The 2008 review from Oslo noted it appears well-tolerated in human use, and the clinical trial in cancer patients didn't report adverse events attributable to the extract.

There are, however, a few cautions worth naming:

• Immunosuppressed individuals: Because AbM actively stimulates immune function, people on immunosuppressive medications (organ transplant recipients, some autoimmune patients) should consult their physician before use. Stimulating an immune system that's being deliberately suppressed for medical reasons can cause problems.
• Blood sugar effects: Some studies suggest AbM may have mild hypoglycemic properties. If you're managing diabetes with medication, monitor your glucose more closely when starting AbM supplementation.
• Extract quality matters enormously: As the Oslo group noted, the biological potency of AbM products varies widely. Low-quality products may simply not work. This isn't a safety issue, but it is a value issue — you could be spending money on something inert if you don't choose carefully.
• Pregnancy: No safety data exists for pregnancy or breastfeeding. Default to caution.

07How to Take Agaricus blazei: Practical Guidance

Given the extract quality variability highlighted in the research, I'd prioritize COA transparency above almost everything else when buying AbM. If a company can't show you third-party testing results including beta-glucan percentage, that's a red flag. The clinical trial that showed NK cell benefits used a specific branded extract (ABMK); the biological activity of generic, poorly characterized products is genuinely unknown.

08Who Should Consider Agaricus blazei?

Based on the available evidence, AbM seems particularly relevant for:

• People going through or recovering from chemotherapy who want immune support (in consultation with their oncologist)
• Anyone focused specifically on NK cell function and innate immune health
• People who want immune support from an evidence-backed source they haven't already tried
• Those interested in anti-inflammatory effects and gut microbiome support
• People with a history of recurrent viral infections (theoretical, based on NK cell mechanism)

It's probably not the first mushroom supplement I'd recommend if someone is starting from scratch — turkey tail has a larger body of high-quality human evidence, particularly for cancer adjuvant use. But as a second addition to a mushroom stack, or as a primary choice for someone specifically interested in NK cell activity and Th1 immune modulation, AbM is a legitimate, evidence-grounded option.

09My Bottom Line

The functional mushroom supplement market has a celebrity problem: the famous ones get all the attention, while genuinely interesting options languish in the background. Agaricus blazei Murill has real human clinical data — actual people in an actual trial showing measurable immune improvement — that compares favorably to the evidence base for several more popular options.

Is it a magic bullet? No. Is the research definitive? Not yet. But it's a safe, well-tolerated, biologically plausible option with a mechanism that makes sense and clinical data that's more direct than "we fed it to mice and their tumor markers improved." In the supplement world, that's worth something.

10Frequently Asked Questions

Is Agaricus blazei the same as AHCC?

No — they're different products with different origins. AHCC (Active Hexose Correlated Compound) is derived from the mycelium of Lentinula edodes (shiitake), not from Agaricus blazei. They both target immune function through different pathways, and both have their own clinical evidence base. Some people use both, but they are distinct supplements.

Can I take Agaricus blazei alongside chemotherapy?

The clinical trial discussed in this article was specifically conducted in chemotherapy patients, and the extract appeared safe in that context. However, you should always inform your oncologist about any supplements you're taking during cancer treatment. Drug interactions and individual circumstances vary, and your care team needs the full picture to give you safe advice.

How does Agaricus blazei's beta-glucan differ from other mushrooms?

Most medicinal mushrooms contain beta-(1→3) and beta-(1→4) linked glucan polysaccharides. Agaricus blazei is notable for its relatively high content of beta-(1→6)-glucans, which appear to interact with immune receptors differently and may explain some of AbM's distinctive biological activity. This structural difference is part of why AbM's immune profile doesn't perfectly overlap with that of, say, reishi or turkey tail — the molecular "key" fits somewhat different "locks" in the immune system.